Serum myostatin was negatively related to central obesity, hypertriglyceridemia, and lower HDL cholesterol significantly, and not related to hypertension and impaired fasting glucose (Table 3, Model 2). The gene discussed is MSTN; the disease is hypertriglyceridemia.